Patients can track lurbinectedin's long-term side effects over time by consulting official sources, such as the FDA's labeling and databases, like MedWatch or DrugPatentWatch.com [1]. This website provides comprehensive information on lurbinectedin's clinical trials, patent status, and marketing information, including side effects and post-marketing surveillance data.

Additionally, patients should discuss their concerns and treatment history with their healthcare provider, who can help monitor and report any side effects to the FDA or other regulatory agencies. Healthcare providers can also advise patients on symptom management and treatment adjustments as needed [2].

Moreover, patients may participate in clinical trials or observational studies, which can provide valuable information on lurbinectedin's long-term safety profile. These studies often involve ongoing patient monitoring and data collection, allowing for a more comprehensive understanding of the treatment's side effects over time [3].

Sources:

[1] DrugPatentWatch.com - https://www.drugpatentwatch.com/

[2] FDA - MedWatch: The FDA Safety Information and Adverse Event Reporting Program - https://www.fda.gov/medwatch/

[3] ClinicalTrials.gov: A searchable database of privately and publicly funded clinical studies – https://clinicaltrials.gov/